Pseudobufarenogin

Cat. No.: X22-05-ZQ213

Pseudobufarenogin

Synonym: 17008-69-4; Pseudobufarenogin; psi-Bufarenogin; 5-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3,12,14-Trihydroxy-10,13-dimethyl-11-oxo-2,3,4,5,6,7,8,9,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one

  • CAS Number: 17008-69-4
  • Compound CID: 204810
Product Size
10 mg; 20 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Pseudobufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling. This product can be used for research in the fields of medicine and pharmacy.
Molecular Weight
416.514
Molecular Formula
C24H32O6
Purity
≥98%, determined by HPLC.
Stability
The product is stable for two years when stored at the recommended temperature.
Form
Powder
Identity
Confirmed by MS and NMR.
Applications
Pseudobufarenogin can be used for research in the fields of medicine and pharmacy.
Storage
Store at 4°C. Protect from light.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.